Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

BACKGROUND: There is strong evidence of under-reporting of harms in manuscripts on randomized controlled trials (RCTs) compared with the volume of raw data retrieved from these trials. Many guidelines have been developed to tackle this, but they have failed to address some important issues that woul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs Aging
Autores principales: Honvo, Germain, Bannuru, Raveendhara R., Bruyère, Olivier, Rannou, Francois, Herrero-Beaumont, Gabriel, Uebelhart, Daniel, Cooper, Cyrus, Arden, Nigel, Conaghan, Philip G., Reginster, Jean-Yves, Thomas, Thierry, McAlindon, Tim
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2019
Materias:
Leading Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509216/
https://ncbi.nlm.nih.gov/pubmed/31073927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-019-00667-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares